Case Study: Cytovance Biologics doubles rhIL-2 titer with Culture Biosciences

Cytovance Biologics doubles rhIL-2 titer in 1 week with Culture Biosciences

The customer, Cytovance Biologics, sought to rapidly optimize a bioprocess for producing a therapeutic protein. They partnered with vendor Culture Biosciences to utilize its high-throughput bioreactor services for this process development challenge.

Culture Biosciences implemented a solution using 52 parallel bioreactors to run a comprehensive design-of-experiments study. This approach generated a detailed process response surface, which identified optimal conditions and doubled the production titer in just one week. The results from Culture Biosciences also provided insights for further process improvements.

Cytovance Biologics